Genertec Net Income Applicable To Common Shares from 2010 to 2026
| 5UM Stock | EUR 0.67 0.01 1.52% |
Net Income Applicable To Common Shares | First Reported 2010-12-31 | Previous Quarter 2.1 B | Current Value 1.5 B | Quarterly Volatility 453.8 M |
Check Genertec Universal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genertec Universal's main balance sheet or income statement drivers, such as Tax Provision of 610.2 M, Net Interest Income of 4.1 M or Interest Income of 60.2 M, as well as many indicators such as . Genertec financial statements analysis is a perfect complement when working with Genertec Universal Valuation or Volatility modules.
Genertec | Net Income Applicable To Common Shares |
The Net Income Applicable To Common Shares trend for Genertec Universal Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Genertec Universal is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Genertec Universal's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Genertec Universal Medical over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Genertec Universal's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genertec Universal's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Genertec Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 1,336,739,759 | |
| Geometric Mean | 1,263,944,337 | |
| Coefficient Of Variation | 33.95 | |
| Mean Deviation | 404,598,832 | |
| Median | 1,352,173,000 | |
| Standard Deviation | 453,815,958 | |
| Sample Variance | 205948.9T | |
| Range | 1.2B | |
| R-Value | 0.90 | |
| Mean Square Error | 40106.2T | |
| R-Squared | 0.82 | |
| Slope | 81,252,297 | |
| Total Sum of Squares | 3295182.8T |
Genertec Net Income Applicable To Common Shares History
About Genertec Universal Financial Statements
Genertec Universal stakeholders use historical fundamental indicators, such as Genertec Universal's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Genertec Universal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genertec Universal's assets and liabilities are reflected in the revenues and expenses on Genertec Universal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genertec Universal Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 2.1 B | 1.5 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Genertec Stock
Genertec Universal financial ratios help investors to determine whether Genertec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genertec with respect to the benefits of owning Genertec Universal security.